Pulmonx
Doug Leahy is a seasoned professional with extensive experience in healthcare reimbursement and support programs. Currently, as the Sr. Manager of the Patient Reimbursement Support Program at Pulmonx Corporation since September 2020, Doug Leahy previously held the role of Vice President of Reimbursement & Health Economics at Caliber Imaging & Diagnostics, Inc., where responsibilities included the execution of health economic strategies and creating awareness among healthcare decision makers. Doug's background also includes nursing experience at Hospice of the Valley, revenue integrity auditing at Abrazo Community Health Network, and reimbursement consulting at The Reimbursement Group. Doug's educational qualifications include a Registered Nursing degree from Aultman College of Nursing and Health Sciences and a Bachelor of Arts in Social Work from Ohio University.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1